From the Lipid Research Group, Department of Vascular Medicine (M.E.W.,
P.W.A.R., L.F., J.C.D., M.P., J.J.P.K.), and the Department of Medical
Statistics (G.-J.T.), Academic Medical Centre, University of Amsterdam, the
Netherlands, and the Department of Medical Genetics, University of British
Columbia, Vancouver, Canada (S.N.P., M.R.H.).
Correspondence to Michael R. Hayden, Department of Medical Genetics, University of British Columbia, 416-2125 E Mall, Vancouver, BC V6T 1Z4, Canada. E-mail mrh{at}ulam.generes.ca
Background—Recently, a mutation in
the lipoprotein lipase (LPL) gene (N291S) has been reported in 2% to
5% of individuals in western populations and is associated with
increased triglyceride (TG) and reduced HDL
cholesterol (HDLC) concentrations.
Methods and Results—Here we report a significant alteration in
biochemical and clinical phenotype in subjects with familial
hypercholesterolemia (FH) who are heterozygous
for this N291S LPL mutation. Sixty-four FH heterozygotes carrying the
N291S mutation had significantly a higher TG level
(P=.004), a higher ratio of total
cholesterol to HDLC (P<.001), and lower
HDLC concentrations (P=.002) compared with 175 FH
heterozygotes without this LPL mutation. Moreover, the N291S mutation
conferred a significantly greater risk for developing
cardiovascular disease in FH heterozygotes compared
with FH heterozygotes without this LPL mutation (odds ratio, 3.875;
P=.006).
Conclusions—These data provide evidence that a common LPL variant
(N291S) significantly influences the biochemical phenotype and
risk for cardiovascular disease in patients with FH.
© 1998 American Heart Association, Inc.
Clinical Investigation and Reports
A Common Mutation in the Lipoprotein Lipase Gene (N291S) Alters the Lipoprotein Phenotype and Risk for Cardiovascular Disease in Patients With Familial Hypercholesterolemia
Key Words: genetics • lipoproteins • atherosclerosis
This article has been cited by other articles:
 |
|
 |
|
  K. C. M. C. Koeijvoets, E. F. C. van Rossum, G. M. Dallinga-Thie, E. W. Steyerberg, J. C. Defesche, J. J. P. Kastelein, S. W. J. Lamberts, and E. J. G. Sijbrands A Functional Polymorphism in the Glucocorticoid Receptor Gene and Its Relation to Cardiovascular Disease Risk in Familial Hypercholesterolemia J. Clin. Endocrinol. Metab., October 1, 2006; 91(10): 4131 - 4136. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Hu, W. Liu, R. Huang, and X. Zhang A systematic review and meta-analysis of the relationship between lipoprotein lipase Asn291Ser variant and diseases J. Lipid Res., September 1, 2006; 47(9): 1908 - 1914. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Koike, J. Liang, X. Wang, T. Ichikawa, M. Shiomi, G. Liu, H. Sun, S. Kitajima, M. Morimoto, T. Watanabe, et al. Overexpression of Lipoprotein Lipase in Transgenic Watanabe Heritable Hyperlipidemic Rabbits Improves Hyperlipidemia and Obesity J. Biol. Chem., February 27, 2004; 279(9): 7521 - 7529. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Merkel, R. H. Eckel, and I. J. Goldberg Lipoprotein lipase: genetics, lipid uptake, and regulation J. Lipid Res., December 1, 2002; 43(12): 1997 - 2006. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. O. Akosah, R. M. Cerniglia, P. Havlik, and A. Schaper Myocardial Infarction in Young Adults With Low-Density Lipoprotein Cholesterol Levels <= 100 mg/dL : Clinical Profile and 1-Year Outcomes Chest, December 1, 2001; 120(6): 1953 - 1958. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. H. McGladdery and J. J. Frohlich Lipoprotein lipase and apoE polymorphisms: relationship to hypertriglyceridemia during pregnancy J. Lipid Res., November 1, 2001; 42(11): 1905 - 1912. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. J. Kim, R. A. Williamson, K. Chen, J. L. Smith, J. C. Murray, and D. C. Merrill Lipoprotein Lipase Gene Mutations and the Genetic Susceptibility of Preeclampsia Hypertension, November 1, 2001; 38(5): 992 - 996. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Levy, D. Menard, E. Delvin, S. Stan, G. Mitchell, M. Lambert, E. Ziv, J. C. Feoli-Fonseca, and E. Seidman The Polymorphism at Codon 54 of the FABP2 Gene Increases Fat Absorption in Human Intestinal Explants J. Biol. Chem., October 19, 2001; 276(43): 39679 - 39684. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Bjorn Lundahl, T. P. Leren, L. Ose, A. Hamsten, and F. Karpe A Functional Polymorphism in the Promoter Region of the Microsomal Triglyceride Transfer Protein (MTP -493G/T) Influences Lipoprotein Phenotype in Familial Hypercholesterolemia Arterioscler. Thromb. Vasc. Biol., July 1, 2000; 20(7): 1784 - 1788. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Clee, N. Bissada, F. Miao, L. Miao, A. D. Marais, H. E. Henderson, P. Steures, J. McManus, B. McManus, R. C. LeBoeuf, et al. Plasma and vessel wall lipoprotein lipase have different roles in atherosclerosis J. Lipid Res., April 1, 2000; 41(4): 521 - 531. [Abstract] [Full Text]
|
|
|
|
 |
|
 K. O. Akosah, E. Gower, L. Groon, B. L. Rooney, and A. Schaper Mild hypercholesterolemia and premature heart disease: do the national criteria underestimate disease risk? J. Am. Coll. Cardiol., April 1, 2000; 35(5): 1178 - 1184. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. E. Wittekoek, E. Moll, S. N. Pimstone, M. D. Trip, P. J. Lansberg, J. C. Defesche, J. J. van Doormaal, M. R. Hayden, and J. J. P. Kastelein A Frequent Mutation in the Lipoprotein Lipase Gene (D9N) Deteriorates the Biochemical and Clinical Phenotype of Familial Hypercholesterolemia Arterioscler. Thromb. Vasc. Biol., November 1, 1999; 19(11): 2708 - 2713. [Abstract] [Full Text] [PDF]
|
|